| 3.7 |
14.9 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 3.6 |
21.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 3.5 |
10.6 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 2.9 |
8.7 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 2.9 |
8.6 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 2.7 |
16.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 2.6 |
7.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 2.6 |
15.9 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 2.6 |
7.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 2.6 |
10.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 2.5 |
7.6 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 2.5 |
2.5 |
GO:0002554 |
serotonin secretion by platelet(GO:0002554) |
| 2.4 |
19.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.4 |
7.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 2.4 |
9.6 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 2.4 |
7.2 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 2.4 |
7.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 2.4 |
9.6 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 2.3 |
7.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 2.3 |
16.1 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 2.2 |
45.0 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 2.2 |
6.7 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 2.2 |
6.5 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 2.1 |
2.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 2.1 |
8.6 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 2.1 |
16.9 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 2.1 |
4.2 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 2.1 |
8.2 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 2.0 |
10.2 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 2.0 |
4.1 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 1.9 |
5.8 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 1.9 |
13.6 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.9 |
11.6 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 1.9 |
3.9 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.9 |
5.8 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 1.9 |
5.7 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.8 |
5.5 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 1.8 |
7.4 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 1.8 |
1.8 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.7 |
23.5 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 1.7 |
5.0 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.6 |
6.6 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) positive regulation of male germ cell proliferation(GO:2000256) |
| 1.6 |
4.8 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.6 |
4.8 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 1.6 |
6.2 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.6 |
4.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.5 |
9.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 1.5 |
4.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 1.5 |
56.4 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 1.5 |
16.7 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 1.5 |
4.5 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 1.5 |
6.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.5 |
2.9 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 1.4 |
10.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.4 |
5.8 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.4 |
38.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 1.4 |
10.0 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 1.4 |
4.2 |
GO:0071156 |
regulation of cell cycle arrest(GO:0071156) negative regulation of cell cycle arrest(GO:0071157) |
| 1.4 |
2.8 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 1.4 |
7.0 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 1.4 |
30.2 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 1.4 |
5.5 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.3 |
4.0 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 1.3 |
4.0 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.3 |
14.6 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 1.3 |
4.0 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 1.3 |
17.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.3 |
3.9 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.3 |
5.2 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 1.3 |
3.9 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 1.3 |
2.6 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.3 |
3.8 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 1.3 |
9.0 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 1.3 |
2.6 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.3 |
1.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 1.3 |
6.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 1.3 |
1.3 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.3 |
1.3 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 1.2 |
1.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 1.2 |
3.7 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 1.2 |
6.0 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.2 |
7.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 1.2 |
3.6 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 1.2 |
3.5 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 1.2 |
3.5 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.2 |
1.2 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.2 |
5.9 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 1.2 |
4.7 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 1.2 |
3.5 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 1.2 |
5.8 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 1.1 |
14.7 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.1 |
4.5 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.1 |
4.5 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.1 |
3.3 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.1 |
4.4 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.1 |
2.2 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 1.1 |
3.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 1.1 |
1.1 |
GO:0031118 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) rRNA pseudouridine synthesis(GO:0031118) |
| 1.1 |
1.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.1 |
18.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 1.1 |
5.4 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 1.1 |
3.2 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 1.1 |
8.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.1 |
3.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 1.1 |
7.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 1.1 |
2.1 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 1.1 |
3.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 1.1 |
5.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.1 |
3.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 |
5.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.0 |
6.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 1.0 |
6.2 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 1.0 |
2.1 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 1.0 |
5.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.0 |
7.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 1.0 |
6.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 1.0 |
14.1 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 1.0 |
3.0 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 1.0 |
2.0 |
GO:0090670 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
| 1.0 |
7.9 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.0 |
10.8 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 1.0 |
8.8 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.0 |
1.0 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 1.0 |
5.8 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 1.0 |
2.9 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 1.0 |
17.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 1.0 |
1.9 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 1.0 |
1.0 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.9 |
2.8 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.9 |
4.7 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.9 |
5.7 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
2.8 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.9 |
3.8 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.9 |
9.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.9 |
9.2 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.9 |
6.4 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.9 |
9.2 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.9 |
33.9 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.9 |
4.6 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.9 |
4.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.9 |
2.7 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.9 |
0.9 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.9 |
2.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.9 |
7.2 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.9 |
8.1 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.9 |
3.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.9 |
2.7 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.9 |
2.7 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.9 |
3.6 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.9 |
4.5 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.9 |
2.7 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.9 |
3.6 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.9 |
2.7 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.9 |
3.5 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.9 |
7.9 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.9 |
0.9 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.9 |
1.8 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.9 |
0.9 |
GO:0034502 |
protein localization to chromosome(GO:0034502) |
| 0.9 |
0.9 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.9 |
0.9 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.9 |
2.6 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.9 |
0.9 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.9 |
2.6 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.9 |
2.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.9 |
29.5 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.9 |
1.7 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.9 |
2.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.9 |
6.0 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.9 |
2.6 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.9 |
7.7 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.8 |
5.9 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.8 |
2.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.8 |
0.8 |
GO:0007008 |
outer mitochondrial membrane organization(GO:0007008) |
| 0.8 |
9.1 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.8 |
8.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.8 |
1.7 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.8 |
28.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.8 |
0.8 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.8 |
3.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 |
4.9 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.8 |
4.9 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.8 |
3.3 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.8 |
16.3 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.8 |
2.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.8 |
2.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.8 |
12.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.8 |
1.6 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.8 |
4.8 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.8 |
3.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.8 |
0.8 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.8 |
4.8 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.8 |
2.4 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.8 |
5.6 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.8 |
2.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.8 |
4.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.8 |
3.2 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.8 |
4.7 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.8 |
3.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.8 |
0.8 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.8 |
5.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.8 |
0.8 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.8 |
2.3 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.8 |
2.3 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.8 |
2.3 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.8 |
5.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.8 |
0.8 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.8 |
3.0 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.8 |
2.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 |
0.8 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.7 |
7.5 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.7 |
0.7 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.7 |
2.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.7 |
11.9 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.7 |
4.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.7 |
4.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.7 |
3.7 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.7 |
3.0 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.7 |
12.6 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.7 |
11.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.7 |
2.9 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.7 |
6.6 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.7 |
2.9 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.7 |
2.9 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.7 |
0.7 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.7 |
2.9 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.7 |
3.6 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.7 |
1.4 |
GO:0060021 |
palate development(GO:0060021) |
| 0.7 |
2.9 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.7 |
28.7 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.7 |
7.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.7 |
5.7 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.7 |
6.4 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.7 |
2.1 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.7 |
1.4 |
GO:1903223 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) positive regulation of oxidative stress-induced neuron death(GO:1903223) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 |
2.1 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.7 |
2.8 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.7 |
2.1 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 |
1.4 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.7 |
4.9 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.7 |
4.9 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.7 |
2.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 |
3.5 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.7 |
3.5 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.7 |
2.8 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.7 |
5.5 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.7 |
1.4 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.7 |
16.4 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.7 |
4.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.7 |
1.4 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.7 |
2.7 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.7 |
2.0 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.7 |
0.7 |
GO:0070203 |
regulation of establishment of protein localization to telomere(GO:0070203) |
| 0.7 |
5.4 |
GO:0034351 |
negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.7 |
0.7 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.7 |
2.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.7 |
6.7 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.7 |
3.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.7 |
16.6 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.7 |
3.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.7 |
2.6 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.7 |
0.7 |
GO:1904707 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.7 |
1.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.7 |
0.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.7 |
3.3 |
GO:0042482 |
positive regulation of odontogenesis(GO:0042482) |
| 0.7 |
2.0 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.7 |
2.0 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.6 |
3.9 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.6 |
5.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.6 |
12.8 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.6 |
2.6 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.6 |
3.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.6 |
2.5 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.6 |
12.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.6 |
1.9 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.6 |
2.5 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.6 |
63.9 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.6 |
2.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.6 |
0.6 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.6 |
2.5 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.6 |
0.6 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.6 |
0.6 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.6 |
3.7 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.6 |
1.2 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.6 |
4.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.6 |
3.0 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.6 |
2.4 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.6 |
1.8 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.6 |
4.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.6 |
5.4 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.6 |
3.6 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.6 |
1.2 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.6 |
2.9 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.6 |
1.2 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.6 |
1.2 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.6 |
6.4 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.6 |
5.3 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.6 |
1.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.6 |
2.3 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.6 |
0.6 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.6 |
1.1 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.6 |
0.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.6 |
0.6 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.6 |
9.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.6 |
7.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.6 |
3.9 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.6 |
1.7 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.6 |
20.7 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.6 |
0.6 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.6 |
2.2 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.6 |
1.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.6 |
3.3 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
| 0.5 |
4.9 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.5 |
8.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.5 |
6.0 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.5 |
2.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.5 |
1.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.5 |
1.6 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.5 |
1.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.5 |
10.7 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.5 |
1.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.5 |
1.1 |
GO:0014045 |
establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
| 0.5 |
3.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
1.6 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 |
1.6 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.5 |
4.2 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.5 |
1.6 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.5 |
1.0 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.5 |
1.0 |
GO:0021508 |
floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.5 |
1.0 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.5 |
3.6 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.5 |
1.0 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.5 |
1.0 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.5 |
3.1 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.5 |
1.0 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 0.5 |
2.6 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.5 |
2.0 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.5 |
1.0 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.5 |
12.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.5 |
1.5 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.5 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.5 |
2.5 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.5 |
1.0 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.5 |
2.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.5 |
1.5 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.5 |
12.9 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.5 |
0.5 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 |
39.4 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.5 |
3.9 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.5 |
2.0 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.5 |
9.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.5 |
4.4 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.5 |
1.5 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.5 |
6.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.5 |
4.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.5 |
1.9 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.5 |
2.4 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.5 |
2.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.5 |
1.9 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.5 |
9.7 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.5 |
1.0 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.5 |
6.7 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.5 |
1.9 |
GO:0071220 |
response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.5 |
4.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.5 |
1.4 |
GO:0060754 |
regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.5 |
1.0 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.5 |
1.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
0.9 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.5 |
1.4 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.5 |
2.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.5 |
3.7 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.5 |
4.2 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.5 |
0.9 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.5 |
2.8 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.5 |
2.3 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 |
7.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 |
0.5 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.5 |
1.4 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.5 |
0.9 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.5 |
1.8 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.4 |
0.4 |
GO:0071426 |
ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.4 |
1.8 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.4 |
0.4 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.4 |
0.9 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.4 |
1.8 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.4 |
2.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 |
1.3 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.4 |
0.9 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
1.3 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.4 |
1.3 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.4 |
1.8 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.4 |
3.5 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 |
1.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
4.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 |
0.4 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 |
0.9 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.4 |
0.9 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.4 |
1.3 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.4 |
0.9 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.4 |
1.3 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.4 |
39.8 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.4 |
1.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.4 |
0.9 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.4 |
0.9 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.4 |
1.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.4 |
0.8 |
GO:0000237 |
leptotene(GO:0000237) |
| 0.4 |
1.7 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.4 |
21.8 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.4 |
5.9 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.4 |
2.5 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.4 |
1.3 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.4 |
0.8 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.4 |
7.5 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.4 |
5.8 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.4 |
2.1 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.4 |
0.8 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.4 |
3.7 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.4 |
2.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 |
3.3 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.4 |
0.8 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.4 |
0.8 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) B cell chemotaxis(GO:0035754) |
| 0.4 |
1.6 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.4 |
1.2 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.4 |
0.4 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 0.4 |
1.2 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.4 |
0.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
0.4 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 |
1.6 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) |
| 0.4 |
2.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.4 |
0.8 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.4 |
2.4 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.4 |
2.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.4 |
2.8 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 |
0.4 |
GO:0006475 |
internal protein amino acid acetylation(GO:0006475) |
| 0.4 |
2.4 |
GO:0035315 |
hair cell differentiation(GO:0035315) neuroepithelial cell differentiation(GO:0060563) |
| 0.4 |
1.2 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.4 |
1.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.4 |
1.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.4 |
3.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.4 |
2.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.4 |
1.6 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.4 |
0.8 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.4 |
1.2 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.4 |
1.2 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.4 |
1.2 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.4 |
1.9 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.4 |
0.4 |
GO:0060631 |
regulation of meiosis I(GO:0060631) |
| 0.4 |
2.3 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.4 |
2.3 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.4 |
1.9 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.4 |
9.1 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.4 |
3.0 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 |
1.1 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.4 |
1.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.4 |
8.3 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.4 |
1.5 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.4 |
2.6 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.4 |
0.4 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.4 |
1.5 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.4 |
2.6 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.4 |
0.4 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.4 |
3.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.4 |
0.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
2.6 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.4 |
0.4 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.4 |
0.4 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.4 |
115.5 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.4 |
1.5 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.4 |
0.7 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.4 |
5.1 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.4 |
1.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
0.7 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.4 |
13.8 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.4 |
1.8 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.4 |
1.4 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.4 |
1.8 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.4 |
1.8 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.4 |
1.8 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.4 |
1.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
1.0 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.3 |
1.7 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
9.7 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.3 |
1.7 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.3 |
2.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.3 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
2.1 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.3 |
1.0 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.3 |
1.7 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
1.0 |
GO:0060217 |
positive regulation of chromatin assembly or disassembly(GO:0045799) hemangioblast cell differentiation(GO:0060217) |
| 0.3 |
1.3 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 |
1.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.3 |
0.3 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.3 |
1.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.3 |
0.3 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.3 |
0.3 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
0.7 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.3 |
2.0 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
16.0 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.3 |
1.0 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.3 |
1.0 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.3 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
3.8 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.3 |
2.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 |
1.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
1.0 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 |
3.8 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.3 |
2.9 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.3 |
5.7 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.3 |
0.6 |
GO:0009838 |
abscission(GO:0009838) |
| 0.3 |
0.9 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.3 |
3.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 |
0.6 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.3 |
1.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 |
0.9 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.3 |
0.6 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.3 |
2.8 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.3 |
2.8 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.3 |
2.5 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.3 |
0.9 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.3 |
2.1 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.3 |
0.6 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.3 |
1.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 |
3.3 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 |
2.4 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.3 |
0.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
0.9 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.3 |
4.8 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.3 |
0.9 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.3 |
0.6 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.3 |
6.6 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.3 |
0.9 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.3 |
0.3 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.3 |
1.2 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.3 |
1.5 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.3 |
7.0 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.3 |
2.6 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.3 |
0.6 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.3 |
0.6 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.3 |
1.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.3 |
2.0 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.3 |
0.6 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
0.9 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.3 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
4.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.3 |
1.1 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 |
0.9 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.3 |
1.7 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
0.9 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.3 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
1.4 |
GO:0070170 |
regulation of tooth mineralization(GO:0070170) |
| 0.3 |
0.8 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
7.3 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.3 |
1.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
4.2 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.3 |
0.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
2.8 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.3 |
0.6 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 0.3 |
1.1 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 |
0.6 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.3 |
1.4 |
GO:0002534 |
cytokine production involved in inflammatory response(GO:0002534) |
| 0.3 |
1.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
6.3 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.3 |
1.4 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.3 |
0.5 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.3 |
3.5 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.3 |
0.8 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
0.3 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.3 |
0.3 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.3 |
2.7 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
1.1 |
GO:0010667 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 |
0.5 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 |
1.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 |
1.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.3 |
15.7 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.3 |
0.5 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.3 |
0.8 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.3 |
1.3 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.3 |
1.6 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.3 |
0.5 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.3 |
3.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 |
1.1 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.3 |
0.5 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
| 0.3 |
0.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.3 |
1.3 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.3 |
5.2 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.3 |
0.3 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.3 |
1.8 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.3 |
1.0 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.3 |
10.1 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.3 |
0.3 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.3 |
1.3 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.3 |
0.5 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.2 |
1.5 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.2 |
1.0 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 |
1.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.2 |
1.7 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
0.7 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.2 |
0.5 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.2 |
0.2 |
GO:0070474 |
regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.2 |
0.5 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.2 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.2 |
0.5 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 |
0.7 |
GO:0072217 |
mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) negative regulation of metanephros development(GO:0072217) |
| 0.2 |
1.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.2 |
3.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 |
0.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.2 |
3.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.7 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
2.8 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
0.2 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.2 |
0.9 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.2 |
0.9 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
0.9 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.2 |
0.5 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.2 |
0.9 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
1.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
0.7 |
GO:1904357 |
negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.2 |
0.5 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.2 |
0.7 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.2 |
0.9 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.5 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.2 |
1.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
0.9 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
0.9 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
4.0 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.2 |
0.9 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
2.4 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.2 |
1.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
2.2 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.2 |
0.9 |
GO:0048659 |
smooth muscle cell proliferation(GO:0048659) |
| 0.2 |
0.9 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 |
1.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
1.5 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.2 |
1.9 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
0.4 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.2 |
3.4 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.2 |
0.9 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
0.6 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.9 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
1.5 |
GO:0042743 |
hydrogen peroxide metabolic process(GO:0042743) |
| 0.2 |
0.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
0.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
0.4 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
1.0 |
GO:0046037 |
GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
| 0.2 |
0.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
1.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
0.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.2 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.2 |
0.6 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
0.4 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.2 |
1.2 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.2 |
0.6 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 |
3.0 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.2 |
0.4 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
0.6 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.2 |
5.6 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.2 |
0.4 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.6 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
1.4 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
0.4 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 |
2.2 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.2 |
3.5 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 |
0.2 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.2 |
1.6 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.2 |
1.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.2 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.2 |
0.2 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.2 |
1.7 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.2 |
3.3 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.6 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.2 |
1.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 |
0.4 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
1.5 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
0.8 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.4 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.2 |
5.5 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.2 |
0.4 |
GO:0070199 |
establishment of protein localization to chromosome(GO:0070199) |
| 0.2 |
4.1 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.2 |
0.4 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.2 |
0.4 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
0.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.2 |
0.4 |
GO:0061045 |
negative regulation of wound healing(GO:0061045) |
| 0.2 |
0.6 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 |
4.6 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.2 |
0.4 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
0.4 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 |
0.5 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.2 |
0.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.2 |
0.5 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.2 |
1.4 |
GO:0002828 |
regulation of type 2 immune response(GO:0002828) |
| 0.2 |
0.4 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.2 |
45.6 |
GO:0006412 |
translation(GO:0006412) |
| 0.2 |
0.9 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
0.7 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
0.5 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
2.1 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.2 |
1.2 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.2 |
1.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
2.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.2 |
5.5 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.2 |
0.5 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.2 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.2 |
0.8 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.7 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.2 |
1.0 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
2.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 |
0.3 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 |
0.5 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
4.4 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 |
0.5 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
0.5 |
GO:0032816 |
positive regulation of natural killer cell activation(GO:0032816) |
| 0.2 |
0.3 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
0.6 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.5 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 |
0.6 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
7.0 |
GO:0034470 |
ncRNA processing(GO:0034470) |
| 0.2 |
0.3 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.2 |
0.6 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 |
6.5 |
GO:0010950 |
positive regulation of endopeptidase activity(GO:0010950) |
| 0.2 |
0.6 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.2 |
0.6 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
0.8 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
1.2 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.9 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
1.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
9.4 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.1 |
1.4 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.4 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 0.1 |
0.6 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.1 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
1.4 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.6 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
1.8 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 |
0.8 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
1.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.3 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 |
1.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.3 |
GO:2001235 |
positive regulation of apoptotic signaling pathway(GO:2001235) |
| 0.1 |
0.7 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.6 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.1 |
1.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
0.3 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 |
1.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.3 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
| 0.1 |
2.3 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.7 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
| 0.1 |
0.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
1.7 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
0.3 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.1 |
3.5 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
1.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.4 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
1.1 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.5 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.1 |
GO:0001820 |
serotonin secretion(GO:0001820) |
| 0.1 |
0.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.2 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.1 |
1.0 |
GO:0010574 |
vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
2.0 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) positive regulation of miRNA metabolic process(GO:2000630) |
| 0.1 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.4 |
GO:0009145 |
purine nucleoside triphosphate biosynthetic process(GO:0009145) ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.1 |
0.5 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
0.6 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
5.9 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
0.5 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
1.6 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.6 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 |
3.1 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 |
4.6 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.2 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.1 |
1.6 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 |
0.1 |
GO:0018410 |
C-terminal protein lipidation(GO:0006501) C-terminal protein amino acid modification(GO:0018410) |
| 0.1 |
0.8 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.1 |
2.3 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.3 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
4.0 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
0.9 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
2.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.4 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
1.2 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.1 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 |
2.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.9 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.6 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.1 |
0.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.6 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.8 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.7 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
| 0.1 |
1.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
3.0 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
0.5 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
1.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.1 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.8 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.5 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
1.7 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.1 |
0.5 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.5 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.8 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
0.5 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.3 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
1.6 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 |
0.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
0.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.3 |
GO:0018377 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.5 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.2 |
GO:0014044 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
0.2 |
GO:0035272 |
exocrine system development(GO:0035272) |
| 0.1 |
0.7 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.4 |
GO:2001028 |
positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.1 |
1.5 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
1.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
2.1 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 |
0.1 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
0.4 |
GO:0002887 |
negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.1 |
0.9 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.3 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 |
0.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.8 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.6 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
0.5 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
1.1 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.2 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
0.2 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.1 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.1 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.5 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.4 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.1 |
0.7 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
2.8 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.2 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.5 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.1 |
1.5 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.1 |
GO:0042762 |
regulation of sulfur metabolic process(GO:0042762) |
| 0.1 |
0.1 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.1 |
2.3 |
GO:0060537 |
muscle tissue development(GO:0060537) |
| 0.1 |
0.3 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.3 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.4 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
1.8 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
1.0 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.1 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.1 |
0.4 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.1 |
0.1 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.2 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.6 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.3 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.1 |
0.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.3 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.5 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.3 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
1.7 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.1 |
0.6 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.1 |
0.1 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.1 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.1 |
0.2 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.3 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 |
0.8 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.8 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.1 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.1 |
0.7 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.1 |
GO:0051852 |
regulation of killing of cells of other organism(GO:0051709) disruption of cells of other organism involved in symbiotic interaction(GO:0051818) disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) killing of cells in other organism involved in symbiotic interaction(GO:0051883) neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
0.4 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.4 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.8 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.1 |
0.2 |
GO:0098840 |
protein transport along microtubule(GO:0098840) |
| 0.1 |
0.3 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
1.0 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.1 |
0.6 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 |
0.4 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.6 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.3 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.2 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.1 |
0.3 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.3 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
0.7 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.6 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.4 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.3 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.2 |
GO:0060113 |
inner ear receptor cell differentiation(GO:0060113) |
| 0.1 |
2.6 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.0 |
0.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.5 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
2.5 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.3 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.0 |
0.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.4 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.6 |
GO:1901343 |
negative regulation of angiogenesis(GO:0016525) negative regulation of vasculature development(GO:1901343) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.2 |
GO:2001020 |
regulation of response to DNA damage stimulus(GO:2001020) |
| 0.0 |
0.1 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.0 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.3 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.2 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.3 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.0 |
0.2 |
GO:0036315 |
cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
| 0.0 |
0.6 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.0 |
0.2 |
GO:0042160 |
plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.0 |
0.2 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
1.0 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.4 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
2.1 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
0.4 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.0 |
0.1 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.0 |
0.0 |
GO:0010665 |
positive regulation of muscle cell apoptotic process(GO:0010661) regulation of cardiac muscle cell apoptotic process(GO:0010665) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.2 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.1 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.0 |
0.2 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.2 |
GO:1902116 |
negative regulation of organelle assembly(GO:1902116) |
| 0.0 |
0.0 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 |
0.1 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.2 |
GO:0035337 |
fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.0 |
1.4 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.0 |
0.1 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.0 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.3 |
GO:0051196 |
regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
| 0.0 |
0.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.2 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.0 |
0.4 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.7 |
GO:0060348 |
bone development(GO:0060348) |
| 0.0 |
0.3 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.0 |
0.2 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
1.1 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.0 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 |
0.1 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.0 |
0.1 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.0 |
0.1 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) collagen biosynthetic process(GO:0032964) regulation of collagen biosynthetic process(GO:0032965) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
1.4 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.0 |
0.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.3 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.0 |
0.0 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.2 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.2 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.0 |
0.2 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.4 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.8 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
3.2 |
GO:0032259 |
methylation(GO:0032259) |
| 0.0 |
0.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.6 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.1 |
GO:0002293 |
alpha-beta T cell activation involved in immune response(GO:0002287) alpha-beta T cell differentiation involved in immune response(GO:0002293) CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) T-helper cell differentiation(GO:0042093) |
| 0.0 |
0.4 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.2 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.2 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
| 0.0 |
0.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.0 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.8 |
GO:0050953 |
sensory perception of light stimulus(GO:0050953) |
| 0.0 |
0.5 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.2 |
GO:0060675 |
ureteric bud morphogenesis(GO:0060675) mesonephric tubule morphogenesis(GO:0072171) |
| 0.0 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.2 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 |
0.0 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.0 |
0.1 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.0 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.0 |
GO:0019748 |
secondary metabolic process(GO:0019748) |
| 0.0 |
0.1 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.3 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.1 |
GO:2000278 |
regulation of DNA biosynthetic process(GO:2000278) |
| 0.0 |
0.2 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.3 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.0 |
0.0 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
